Evidence map›Paper›PMID 36539803›Full record

ArticleJournal of neuroinflammation2022

Zika virus infection of mature neurons from immunocompetent mice generates a disease-associated microglia and a tauopathy-like phenotype in link with a delayed interferon beta response.

Caroline Manet, Zeyni Mansuroglu, Laurine Conquet, Violaine Bortolin, Thomas Comptdaer, Helena Segrt, Marie Bourdon, Reyene Menidjel, Nicolas Stadler, Guanfang Tian and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. bTInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Modeling extrahepatic hepatitis E virus infection in induced human primary neurons.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Caroline Manet *Institut Pasteur, Mouse Genetics Laboratory, Université de Paris, 75015, Paris, France.
Zeyni Mansuroglu *Université Paris Cité, Institut Cochin, Inserm, CNRS, 75014, Paris, France.
Laurine ConquetInstitut Pasteur, Mouse Genetics Laboratory, Université de Paris, 75015, Paris, France.
Violaine BortolinUniversité Paris Cité, Institut Cochin, Inserm, CNRS, 75014, Paris, France.
Thomas ComptdaerUniversity Lille, Inserm, CHU Lille, Inserm, LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.
Helena SegrtUniversité Paris Cité, Institut Cochin, Inserm, CNRS, 75014, Paris, France.
Marie BourdonInstitut Pasteur, Mouse Genetics Laboratory, Université de Paris, 75015, Paris, France.
Reyene MenidjelUniversité Paris Cité, Institut Cochin, Inserm, CNRS, 75014, Paris, France.
Nicolas StadlerUniversité Paris Cité, Inserm UMR1124, 75006, Paris, France.
Guanfang TianUniversité Paris Cité, Institut Cochin, Inserm, CNRS, 75014, Paris, France.
Floriane HeritUniversité Paris Cité, Institut Cochin, Inserm, CNRS, 75014, Paris, France.
Florence NiedergangUniversité Paris Cité, Institut Cochin, Inserm, CNRS, 75014, Paris, France.
Sylvie SouèsUniversité Paris Cité, Institut Cochin, Inserm, CNRS, 75014, Paris, France.
Luc BuéeUniversity Lille, Inserm, CHU Lille, Inserm, LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.
Marie-Christine Galas *University Lille, Inserm, CHU Lille, Inserm, LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France.
Xavier Montagutelli *Institut Pasteur, Mouse Genetics Laboratory, Université de Paris, 75015, Paris, France.
Eliette Bonnefoy *Université Paris Cité, Institut Cochin, Inserm, CNRS, 75014, Paris, France. eliette.bonnefoy@inserm.fr.
Centre National de la Recherche Scientifique · FRInstitut Cochin · FRInstitut Pasteur · FRCentre Hospitalier Universitaire de Lille · FRDélégation Paris 5 · FRInserm · FRUniversité de Lille · FRUniversité Paris Cité · FR

Funding

Agence Nationale de la Recherche NeuroZika (ANR-20-CE16-0017)Labex, France DISTALZLabex, France IBEID
6 · The paper itself

Abstract

backgroundZika virus (ZIKV) infection at postnatal or adult age can lead to neurological disorders associated with cognitive defects. Yet, how mature neurons respond to ZIKV remains substantially unexplored.

methodsThe impact of ZIKV infection on mature neurons and microglia was analyzed at the molecular and cellular levels, in vitro using immunocompetent primary cultured neurons and microglia, and in vivo in the brain of adult immunocompetent mice following intracranial ZIKV inoculation. We have used C57BL/6 and the genetically diverse Collaborative Cross mouse strains, displaying a broad range of susceptibility to ZIKV infection, to question the correlation between the effects induced by ZIKV infection on neurons and microglia and the in vivo susceptibility to ZIKV.

resultsAs a result of a delayed induction of interferon beta (IFNB) expression and response, infected neurons displayed an inability to stop ZIKV replication, a trait that was further increased in neurons from susceptible mice. Alongside with an enhanced expression of ZIKV RNA, we observed in vivo, in the brain of susceptible mice, an increased level of active Iba1-expressing microglial cells occasionally engulfing neurons and displaying a gene expression profile close to the molecular signature of disease-associated microglia (DAM). In vivo as well as in vitro, only neurons and not microglial cells were identified as infected, raising the question of the mechanisms underlying microglia activation following brain ZIKV infection. Treatment of primary cultured microglia with conditioned media from ZIKV-infected neurons demonstrated that type-I interferons (IFNs-I) secreted by neurons late after infection activate non-infected microglial cells. In addition, ZIKV infection induced pathological phosphorylation of Tau (pTau) protein, a hallmark of neurodegenerative tauopathies, in vitro and in vivo with clusters of neurons displaying pTau surrounded by active microglial cells.

conclusionsWe show that ZIKV-infected mature neurons display an inability to stop viral replication in link with a delayed IFNB expression and response, while signaling microglia for activation through IFNs-I secreted at late times post-infection. In the brain of ZIKV-infected susceptible mice, uninfected microglial cells adopt an active morphology and a DAM expression profile, surrounding and sometimes engulfing neurons while ZIKV-infected neurons accumulate pTau, overall reflecting a tauopathy-like phenotype.

Indexed as

TauopathiesZika VirusZika Virus InfectionAnimalsInterferon-betaMiceMice, Inbred C57BLNeuronsPhenotypeVirus ReplicationInterferon-betaCollaborative crossDisease associated microgliaFlavivirusInterferon betaMicroglia activationNeuronal viral infectionNeuron-microglia crosstalkTau proteinType I interferon signalingZika virus

Identifiers

PMID36539803
PMCPMC9764315
OpenAlexW4312114221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.